-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse London Stock ExchangeGBpISIN GB0009895292-
AstraZenecaBörse London Stock ExchangeGBpISIN GB0009895292 WKN: 886455
-
AstraZeneca PLCBörse London Stock ExchangeISIN US046353AX64
-
AstraZeneca PLCBörse London Stock Exchange
-
ASTRAZENECA PLCBörse Börse StuttgartISIN US046353AU26EURSymbol ZEG
-
AstraZenecaBörse Xetra FrankfurtISIN US046353AQ14EURSymbol ZEG
-
ASTRAZENECA PLCBörse Gettex System der Börse MünchenEURSymbol ZEG
-
ASTRAZENECA PLCBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol ZEG
-
ASTRAZENECA PLCBörse Quotrix System der Börse DüsseldorfEURSymbol ZEG
-
ASTRAZENECA PLCBörse Börse HamburgEURSymbol ZEG
-
ASTRAZENECA PLCBörse Börse DüsseldorfEURSymbol ZEG
-
AstraZeneca PLCBörse Xetra FrankfurtISIN US046353AR96
-
AstraZenecaBörse Amerikanscher Freiverkehr OTC oder "Pink Sheets"ISIN GB0009895292 WKN: 886455USDSymbol AZN
-
AstraZeneca PLCBörse Nasdaq
-
ISIN US046353AN82EURSymbol ZEG
-
ISIN US046353AS79EURSymbol ZEG
-
EURSymbol ZEG
-
AstraZeneca PLCBörse OMXSISIN US046353AZ13
-
EURSymbol AZN.LN
-
EURISIN US046353AG32
-
AstraZeneca PLCBörse Bolsa Mexicana de Valore Mexiko-StadtISIN US0463531089
-
EUR
-
AstraZeneca PLCBörse Freiverkehr OTC
-
ISIN GB0009895292
WKN 886455
Firmenname
AstraZeneca PLC
Marktkapitalisierung
129.358.538.728 (+- 6%)
Die einen sagen so, die anderen so... Es gibt 3 Datenquellen:
137.591.537.664 oder 121.186.000.000 oder 129.298.078.520
Mitarbeiter
77.050 (+- 8%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
70.600 oder 83.500 Mitarbeiter
Anzahl Aktien
1.312.138.000
KGV
69.31 (+- 7%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
64.72 oder 73.9
EBITDA 6.904.000.000
PEGRatio 1.3036
Buchwert 4.6635
Zahlte zuletzt am 25.02.2021 eine Dividende von 137,4 . Seit damals wurde keine Dividende mehr ausgeschüttet Übersicht
AstraZeneca underperformed den DAX um -8 % vom 05.07.2021 bis 15.09.2021
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 91,81 EUR -0,09%
Aktionärsstruktur der AstraZeneca PLC
Portrait der AstraZeneca Aktie
Das Unternehmen AstraZeneca PLC aus Großbritannien beschäftigt 77.050 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Medizinische Produkte / Medizintechnik, Biotechnologie & Pharmazeutika, Pharma tätig.
ASTRAZENECA PHARMA INDIA LTD ist ein Tochterunternehmen von AstraZeneca.
Die AstraZeneca Aktie hat inklusive der Dividendenausschüttungen seit dem 05.07.2021 leider keine Rendite erwirtschaften. Die Kursverluste lagen selbst inklusive ausgeschütteter Dividenden bei insgesamt -7%.
Das Unternehmen AstraZeneca PLC ist in mehr als 74 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter iShares STOXX Europe 600 Health Care UCITS ETF (DE) gewichtet AstraZeneca mit 9,81% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle AstraZeneca Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen AstraZeneca PLC am höchsten gewichtet ist Insgesamt in 74 ETFs enthalten
Dir gefallen die Informationen zu AstraZeneca?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu AstraZeneca?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu AstraZeneca?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu AstraZeneca?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
495 News & Informationen zur AstraZeneca Aktie
The Week Ahead In Biotech (Jan 10-16): Expect Stocks To Move As J.P. Morgan Healthcare Conference Kicks Off
JPMorgan Chase & Co. CEO Jamie Dimon is to be among the keynote speakers at next week's J.P. Morgan Healthcare Conference.
After ending 2020 in …
Better Coronavirus Stock: AstraZeneca vs. Pfizer
Here's how these two huge COVID-19 vaccine makers compare.
AstraZeneca : Russia's Gamaleya applies for emergency vaccine use in Philippines
Russia's Gamaleya Research
Institute has applied to the Philippine health regulator for
emergency use authorisation of its COVID-19 vaccine but needs to
file further documentation, the regulator said… | January 9, 2021
AstraZeneca : NHS England plans to vaccinate all frontline staff against COVID-19 in next few weeks
NHS England said on Friday it had made
plans to vaccinate all frontline staff against COVID-19 in the
next few weeks following the rollout of the Oxford-AstraZeneca
vaccine.
Nikita… | January 9, 2021
Moderna’s Covid-19 Vaccine Is Authorized by U.K. Regulator
The U.K.’s health regulator authorized the use of Moderna’s Covid-19 vaccine, boosting the number of different shots at the country’s disposal to three as it battles a contagious new variant of the virus.
Pharma Stock Roundup: ABBV's Positive Skyrizi Data, AZN, PFE, RHHBY's FDA Updates
AbbVie's (ABBV) Skyrizi succeeds in psoriatic arthritis and Crohn's disease studies. AstraZeneca (AZN), Pfizer (PFE) and Roche (RHHBY) give FDA updates.
SHAREHOLDER ALERT: WeissLaw LLP Reminds EIDX, IPHI, ALXN, And XLNX Shareholders About Its Ongoing Investigations
NEW YORK, Jan. 6, 2021 /PRNewswire/ —
If you own shares in any of the companies listed above and would like to discuss our investigations or have
SHAREHOLDER ALERT: WeissLaw LLP Reminds EIDX, IPHI, ALXN, and XLNX Shareholders About Its Ongoing Investigations
/PRNewswire/ — If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this…
Yong Tai finalising plans for commercialisation of Covid-19 vaccine
PETALING JAYA: Yong Tai Bhd is finalising its plans for the commercialisation of Covid-19 vaccine with Shenzhen Kangtai Biological Products Co Ltd (SZ…
My 2 best shares for 2021
As the New Year starts, now is the perfect time to look for investments that should do well this year. Here are two of my best shares for 2021
2 Top Value Stocks to Own in 2021
AstraZeneca and Gilead Sciences should rebound nicely this year.
AstraZeneca (AZN) Farxiga Gets Priority Tag for Kidney Disease
If approved for CKD, AstraZeneca’s (AZN) Farxiga will be the first SGLT2 inhibitor approved to treat patients with CKD, with and without type II diabetes.
Covid variant found in South Africa is worrying experts: Here’s what we know so far
A new strain of the coronavirus that has emerged in South Africa is causing concern around the globe.
Astrazeneca (AZN) Gains But Lags Market: What You Should Know
In the latest trading session, Astrazeneca (AZN) closed at $50.70, marking a +0.36% move from the previous day.
Chilean lawmakers propose making coronavirus vaccine mandatory
Chilean lawmakers on Tuesday
presented a bill before Congress that would make vaccination
against the coronavirus mandatory as the country’s center-right
government pushes to inosculate the majority… | January 5, 2021
Health-care picks for portfolios
Vaccines, therapeutics provide growth opportunities
Israel to enter third national lockdown despite successful Covid vaccination campaign
Israel braces for a third national lockdown even with the nation seeing success in the rollout of the Pfizer BioNTech vaccine
EU In Talks To Buy Up To 300M More Coronavirus Vaccine Doses From Pfizer-BioNTech
With the U.K. entering a third nationwide lockdown and the COVID-19 pandemic raging through the rest of Europe, vaccines approved for emergency use …
Serum, Bharat Biotech announce ‘combined intent’ to supply vaccines
Read more about Serum, Bharat Biotech announce ‘combined intent’ to supply vaccines on Business Standard. The more important task right now is of saving the lives and livelihoods of populations in India and around the world, a joint statement by both companies said
India’s Covid-19 vaccination challenge needs a private sector helping hand
Read more about India’s Covid-19 vaccination challenge needs a private sector helping hand on Business Standard. The media and opposition figures have justifiably asked why Bharat Biotech’s candidate was approved at the same time as AstraZeneca’s, when it hasn’t even finished or published results from Stage III
Moderna vaccine: ‘A slower rollout than we were hoping’ for B.C., says Henry
B.C. officials plan to vaccinate 70,000 residents and staff at long-term care facilities by the end of January — nearly half of all British Columbians who are expected to receive their first dose against COVID-19 by month’s end.
New Year’s Resolutions and Vaccine Distributions
New Year’s Resolutions and Vaccine Distributions, Stocks: SNOW,ABNB,DASH,AMZN,NFLX,DASH,ZM,PFE,MRNA,JNJ,AZN, release date:Jan 04, 2021
New Year’s Resolutions and Vaccine Distributions
New Year’s Resolutions and Vaccine Distributions, Stocks: SNOW,ABNB,DASH,AMZN,NFLX,DASH,ZM,PFE,MRNA,JNJ,AZN, release date:Jan 04, 2021
U.K. Imposes Third National Lockdown Until Mid-February
Prime Minister Boris Johnson ordered the British population to stay home until mid-February amid spiraling infection rates caused by a new variant of the coronavirus.
ROUNDUP: Starker Anstieg von Corona-Fllen – Johnson verhngt Lockdown
ROUNDUP: Starker Anstieg von Corona-Fllen – Johnson verhngt Lockdown | Nachricht | finanzen.net
AstraZeneca : Bharat Biotech aims to make 700 million doses of COVID-19 vaccine in 2021
India’s Bharat Biotech is aiming to have a production capacity of about 700 million doses of its COVID-19 vaccine this year, according to a top executive of the biotechnology company…. | January 4, 2021
UK faces third lockdown as surge in cases threatens to overwhelm hospitals
Read more about UK faces third lockdown as surge in cases threatens to overwhelm hospitals on Business Standard. The UK government is back in crisis mode with new virus cases exceeding 50,000 a day
Stocks making the biggest moves in the premarket: Magellan Health, FLIR Systems, Tesla & more
The stocks making the biggest moves in premarket trading include Magellan Health, FLIR Systems, Tesla, and more.
First country rolls out AstraZeneca-Oxford vaccine as EU faces challenges with its inoculations.
An 82-year-old dialysis patient has become the first person to receive the AstraZeneca–Oxford COVID-19 vaccine.
Mining sector drives big rally for FTSE 100 as gold and other metals surge
U.K. stocks surged on Monday, buoyed by a rally for the mining sector as metals futures jumped.
Oil prices touch multi-month highs as OPEC+ expected to cap output
LONDON -Oil prices touched multi-month highs on Monday on expectations OPEC and allied producers may cap output at current levels in February and on hopes that coronavirus vaccines may help curb the… | January 4, 2021
Vaccine News May Make AstraZeneca Stock Seem Worth a Shot, But It’s Not
The U.K. greenlighted AstraZeneca’s vaccine, but don’t take that as a signal to buy. AZN stock looks terrible.
UK rolls out Oxford-AstraZeneca vaccine as it battles against Covid surge
The U.K. is to start rolling out the coronavirus vaccine developed by AstraZeneca and the University of Oxford on Monday.
Covaxin: Science, not pride will help India build trust in this vaccine
Read more about Covaxin: Science, not pride will help India build trust in this vaccine on Business Standard. The hasty nod for Bharat Biotech’s Covaxin, developed in collaboration with the ICMR and National Institute of Virology, has raised eyebrows in the scientific and healthcare communities
View: India’s vaccine nationalism is a global risk
To be sure, India is not even in the front row of vaccine nationalism. China and Russia are more desperate to beat the West in saving the world. But both countries candidates face transparency deficit, which could limit their global acceptance. Thats a risk that India, which makes more than 60% of the worlds vaccines, should avoid at all cost.
Vietnam says to buy AstraZeneca vaccine, in talks with other producers
Vietnam has agreed to buy 30 million doses of the COVID-19 vaccine produced by AstraZeneca Plc, the government said on Monday, adding that authorities are also seeking to purchase vaccines from other sources, including Pfizer Inc. The Southeast Asian country has previously agreed to get a Russian vaccine though also said it would not rush to secure vaccine deals, citing the potential for high financial costs and after managing to contain its coronavirus outbreaks to only 1,494 cases, with 35 deaths. The AstraZeneca and Oxford University COVID-19 vaccine is cheaper than some others and can be stored at fridge temperature, which makes it easier to transport and use, particularly in developing countries.
Grobritannien bereitet Impfungen mit AstraZeneca-Impfstoff vor – Auch Indien gewhrt Notfallzulassung
In Grobritannien bereiten sich Krankenhuser und Arztpraxen auf den Impfstart mit dem heimischen Prparat der Universitt Oxford und des Pharmakonzerns AstraZeneca vor. 04.01.2021
AstraZeneca and University of Oxford’s Coronavirus Vaccine Approved in India
The massive country gives AZD1222 the nod for emergency use, in addition to a vaccine from local company Bharat Biotech.
India Authorizes Covid-19 Vaccines and Readies Inoculation Campaign
Officials plan to vaccinate 300 million in the coming months to protect citizens and the economy from the pandemic.
Africa left with few options for vaccines, South Africa says
Africa has few options to procure Covid-19 vaccines as the outbreak of the disease worsens across many parts of the continent, South Africa’s presidency said.